Latar belakang. Kolostrum susu sapi atau Bovine colostrum mengandung berbagai growth factor dan immune factor, salah satunya secretory IgA (sIgA) yang dengan jumlah signifikan dapat menghalangi ...adhesi patogen ke membrane mukosa dan menghambat kolonisasi sehingga bermanfaat untuk mengobati penyakit di saluran pencernaan. Penelitian yang telah dilakukan di Indonesia belum banyak membahas secara spesifik hubungan sIgA yang didapatkan dari kolostrum susu sapi sebagai terapi tambahan diare akut pada anak. Tujuan. Mengetahui pengaruh pemberian kolostrum susu sapi terhadap durasi diare akut dehidrasi ringan sedang dan kadar sekretori IgA pada anakMetode. Penelitian eksperimental yang dilaksanakan di Puskesmas dan Rumah Sakit di kota Padang. Penelitian dimulai dari bulan februari tahun 2022 sampai November 2022. Data terkumpul 30 sampel masing-masing pada kelompok kontrol yang mendapatkan terapi standar WHO dan kelompok intervensi yang mendapatkan terapi standar who ditambah kolostrum susu sapi. Dilakukan pengamatan terhadap durasi diare akut serta pemeriksaan terhadap kadar sIgA.Hasil. Terjadi pemendekan durasi diare secara signifikan antara kelompok intervensi dan kelompok kontrol sebesar 11,93 jam (p=0,021). Terdapat perbedaan kadar sIgA yang signifikan antara sebelum dan sesudah pemberian kolostrum susu sapi pada kelompok intervensi (p=0,003).Kesimpulan. Pemberian kolostrum susu sapi dapat memperpendek rerata durasi diare akut dan meningkatkan rerata kadar sIgA secara bermakna. Pemberian kolostrum susu sapi ini dapat disarankan sebagai terapi adjuvan dalam tatalaksana diare akut pada anak.
•Alhagi honey polysaccharides could increase pIgR secretion in Caco-2 cell in vitro.•Alhagi honey polysaccharides could significantly induce DCs maturation in vitro.•Alhagi honey polysaccharides ...could enhance sIgA in gut of cyclophosphamide-mice.•Alhagi honey polysaccharides could activate the DCs in cyclophosphamide-mice.
It remains a huge challenge to recover the intestine immune function for the treatment of intestinal mucosal damage from chemotherapy with cyclophosphamide (CY). Alhagi honey polysaccharide (AH) has immunomodulation pharmacological activity, but the effect and mechanism on the intestinal immune system of CY-mice remain unclear.
In this experiment, the immunomodulatory activity of AH on intestinal immune in CY-mice and its mechanism of regulating the intestinal immune system was investigated.
The experiment studied the immunomodulatory activity of AH on the intestinal immune system and its mechanism for the first time from in vitro and in vivo experiments. We investigated the immunomodulatory effects of AH on Caco-2 and dendritic cells (DCs) in vitro by using western blot (WB), flow cytometry, quantitative real-time PCR (qPCR), and ELISA methods. In vivo experiment, the immunosuppressive mouse model was established through being given intraperitoneal injection with CY (80 mg/kg) for 3 days. Then, mice oral administration of 800 mg/kg AH and 40 mg/kg levamisole hydrochloride for a week. Immunofluorescence, flow cytometry, ELISA, qPCR and WB were applied to examine the immunomodulatory activity of AH on the intestinal immune function of CY-mice, as well as the function of AH on the concentration of SCFAs in cecum by Gas chromatographic analysis.
In vitro experiments, AH could significantly stimulate the expression of pIgR protein in Caco-2. It could also induce the DCs maturation and release the cytokines to regulate the immune response. In vivo experiments, AH could remarkably stimulate the DCs maturation and secrete more CCL20 to recruit DCs, then induce the T (CD4+ and CD8+) and B cells proliferation and activation. Moreover, it could further induce T helper cells to differentiate and secrete cytokines to enhance the secretion of sIgA. Furthermore, it also directly activated DCs and released cytokines to increase the content of pIgR, J-chain, and IgA+ cells in intestine, thereby enhancing the secretion of sIgA to protect the intestine. In addition, AH could obviously strengthen the SCFAs production in cecum to regulate the intestinal immune dysfunction induced by CY.
In summary, oral administrated AH exhibits great benefits for treating CY-induced intestinal immunosuppression, and the mechanism of action mainly involves sIgA, DCs, SCFAs.
The leading role associated with an anti-infective action of breast milk belongs to secretory IgA (SIgA). Therefore, the determination of the level of SIgA in colostrum and milk of mothers with ...different lactation levels and mothers at risk at different levels and duration of lactation has a practical interest.
Aim. The research aims at studying the dynamics of SIgA content in breast milk, taking into account risk factors and features of lactation.
Material and Methods. The content of SIgA in colostrum and breast milk of 372 mothers with full lactation and 208 with hypogalactia, of which 72 with early and 146 with late hypogalactia at different times of lactation (1-8 days and 1-3 months) was determined. The SIgA content was also studied in mothers; 65 with preeclampsia, including 12 with early hypogalactia, 24 with late hypogalactia, 23 with full lactation, and 44 with anemia of pregnancy, including 12 with early hypogalactia, 19 with late hypogalactia and 13 with full lactation. The determination of SIgA content in colostrum and milk was performed using the method of simple radial immunodiffusion in a gel by G. Mancini et al.
Results and Discussion. The SIgA concentration in colostrum and breast milk decreased during the secretion process. In early hypogalactia, the content of SIgA did not differ significantly from the level of SIgA in colostrum and breast milk with full lactation in the early neonatal period and at 1-3 months of secretion. In the late hypogalactia, SIgA content did not differ significantly from its level in the control group. Due to the lower amount of milk received by the mother's child with hypogalactia, the supply of children with SIgA is insufficient, and the deficit is higher the sooner the hypogalactia develops. Similar changes in the dynamics of SIgA content have been found in mothers with preeclampsia and at different levels of lactation. The exception was the content of SIgA in colostrum and milk of mothers with anemia of pregnancy and early hypogalactia, which in the first five days of lactation was lower than in mothers with full lactation.
Conclusion. The SIgA concentration in colostrum and breast milk decreases during the secretion process. The level of lactation does not affect the dynamics of SIgA content, except for the SIgA content in colostrum and breast milk of mothers with anemia of pregnancy and hypogalactia in the early stages of secretion. Despite the absence of a significant difference in SIgA levels in mothers with different levels of lactation due to less colostrum and milk received by children with early and late hypogalactia, the supply of SIgA is insufficient, and the cumulative deficit is higher the faster the hypogalactia develops.
Latar belakang. Air susu ibu (ASI) berperan penting dalam sistem kekebalan innate bayi baru lahir. Kolostrum telah diketahui mengandung antibodi terbesar yaitu sIgA yang berasal dari ...Entero-broncho-Mammary Pathway. Sekretori IgA kolostrum merupakan imunomodulator perkembangan sistem imun bayi baru lahir. Antibodi pada ASI sering dihubungkan dengan perlindungan bayi terhadap infeksi sampai usia 6 bulan. Masih perlu diketahui peranan sIgA kolostrum terhadap kejadian infeksi Balita.Tujuan. Membuktikan hubungan antara kadar sIgA kolostrum dengan frekuensi infeksi umum dan infeksi saluran pernapasan akut (ISPA) pertahun pada Balita. Mengetahui faktor lain yang berhubungan dengan infeksi Balita secara umum.Metode. Studi prospektif pada 53 Balita usia 3 tahun dengan riwayat kehamilan cukup bulan, lahir sehat beserta ibunya. Pengumpulan ASI pada hari ke 2-3 postpartum, sIgA diukur dengan teknik ELISA. Data didapat dari kuesioner dengan kunjungan rumah atau pertelepon. Analisis statistik menggunakan uji Mann-Whitney, chi-square dan Fisher.Hasil. Rerata frekuensi infeksi umum kelompok riwayat kadar sIgA kolostrum rendah (<120mg/dL) lebih sering dibanding kelompok kontrol (5,9 vs 4,2, p=0,03), demikian juga frekuensi ISPA lebih sering dibanding kontrol (5,2 vs 3,8, p=0,041). Terdapat hubungan antara kepadatan hunian dengan sering infeksi, p=0,01.Kesimpulan. Balita dengan riwayat sIgA kolostrum ibu rendah (<120mg/dL) lebih sering mengalami infeksi saluran pernapasan akut dan infeksi secara umum dibanding kontrol. Kepadatan hunian berhubungan dengan riwayat sering infeksi.
The level of secretory immunoglobulin A (SIgA) in saliva is associated with the risk of upper respiratory infection and has been identified as a condition indicator for athletes and an indicator of ...mucosal immune function in the elderly. In addition, it has been suggested that non-specific polyreactive SIgA is present in human saliva and colostrum. The purpose of this study was to establish a new detection method of polyreactive salivary SIgA. Using saliva samples from eight healthy individuals, indirect ELISA was used to detect anti-LPS antibodies (LPS ELISA), and competitive ELISA was used to detect LPS antibodies after competition with DNA (LPS-DNA ELISA). The difference in SIgA concentration between LPS ELISA and LPS-DNA ELISA is thought to be the concentration of the polyreactive SIgA, which responds to both DNA and LPS. First, we determined the concentration for coating LPS and DNA as 10 μg/ml, and the saliva sample dilution was determined as 1/2. The concentration of anti-LPS antibody contained in the saliva sample, which is strongly reactive to LPS, was defined as the standard. Compared to the SIgA concentration determined by LPS ELISA, SIgA concentration of LPS-DNA ELISA did not decrease in two samples, but was reduced in 6 samples. The decrease in SIgA concentration is thought to be the concentration of polyreactive SIgA that reacts with both DNA and LPS. Notably, we found sample-to-sample differences in the concentration of polyreactive SIgA.
Enterohemorrhagic
(EHEC) has consistently been one of the foremost foodborne pathogen threats worldwide based on the past 30 years of surveillance. EHEC primarily colonizes the bovine ...gastrointestinal (GI) tract from which it can be transmitted to nearby farm environments and remain viable for months. There is an urgent need for effective and easily implemented pre-harvest interventions to curtail EHEC contamination of the food and water supply. In an effort to address this problem, we isolated single-domain antibodies (V
Hs) specific for intimin, an EHEC adhesin required for colonization, and designed chimeric V
H fusions with secretory IgA functionality intended for passive immunotherapy at the mucosal GI surface. The antibodies were produced in leaves of
with production levels ranging between 1 and 3% of total soluble protein.
assembly of all subunits into a hetero-multimeric complex was verified by co-immunoprecipitation. Analysis of multivalent protection across the most prevalent EHEC strains identified one candidate antibody, V
H10-IgA, that binds O145:Hnm, O111:Hnm, O26:H11, and O157:H7. Fluorometric and microscopic analysis also indicated that V
H10-IgA completely neutralizes the capacity of the latter three strains to adhere to epithelial cells
. This study provides proof of concept that a plant-produced chimeric secretory IgA can confer cross-serotype inhibition of bacterial adhesion to epithelial cells.
Summary
Introduction
Among sensitized infants, those with high, as compared with low levels, of salivary secretory IgA (SIgA) are less likely to develop allergic symptoms. Also, early colonization ...with certain gut microbiota, e.g.
Lactobacilli
and
Bifidobacterium
species, might be associated with less allergy development. Although animal and
in vitro
studies emphasize the role of the commensal gut microbiota in the development of the immune system, the influence of the gut microbiota on immune development in infants is unclear.
Objective
To assess whether early colonization with certain gut microbiota species associates with mucosal and systemic immune responses i.e. salivary SIgA and the spontaneous Toll‐like receptor (TLR) 2 and TLR4 mRNA expression and lipopolysaccharide (LPS)‐induced cytokine/chemokine responses in peripheral blood mononuclear cells (PBMCs).
Methods
Fecal samples were collected at 1 week, 1 month and 2 months after birth from 64 Swedish infants, followed prospectively up to 5 years of age. Bacterial DNA was analysed with real‐time PCR using primers binding to
Clostridium difficile
, four species of bifidobacteria, two lactobacilli groups and
Bacteroides fragilis
. Saliva was collected at age 6 and 12 months and at 2 and 5 years and SIgA was measured with ELISA. The PBMCs, collected 12 months after birth, were analysed for TLR2 and TLR4 mRNA expression with real‐time PCR. Further, the PBMCs were stimulated with LPS, and cytokine/chemokine responses were measured with Luminex.
Results
The number of
Bifidobacterium
species in the early fecal samples correlated significantly with the total levels of salivary SIgA at 6 months. Early colonization with
Bifidobacterium
species, lactobacilli groups or
C. difficile
did not influence TLR2 and TLR4 expression in PBMCs. However, PBMCs from infants colonized early with high amounts of
Bacteroides fragilis
expressed lower levels of TLR4 mRNA spontaneously. Furthermore, LPS‐induced production of inflammatory cytokines and chemokines, e.g. IL‐6 and CCL4 (MIP‐1β), was inversely correlated to the relative amounts of
Bacteroides fragilis
in the early fecal samples.
Conclusion
Bifidobacterial diversity may enhance the maturation of the mucosal SIgA system and early intense colonization with
Bacteroides fragilis
might down‐regulate LPS responsiveness in infancy.
The infant gut microbiota is critical for promoting and maintaining early-life health. The study aimed to analyze the composition of sIgA-coated and sIgA-uncoated bacterial communities at genus level ...and lactobacilli and bifidobacterial communities at species level in human breast milk (HBM) and infant and maternal feces. Eleven pregnant women were recruited successfully. HBM; infant feces during colostrum, transition, and mature stages; and maternal feces within the mature stage were collected. sIgA-coated and sIgA-uncoated bacteria were separated with magnetic-activated cell sorting. Then, 16S rRNA sequencing, bifidobacterial groEL gene sequencing, and lactobacilli groEL gene sequencing were performed to analyze the bacterial community. PCoA revealed that the compositions of sIgA-coated and sIgA-uncoated bacteria were different among HBM and infant and maternal feces. Higher relative abundance of sIgA-uncoated Bifidobacterium was found in the three lactation stages in infant feces compared to the corresponding HBM, and a higher relative abundance of sIgA-uncoated Faecalibacterium was found in maternal feces compared to HBM and infant feces. For bifidobacterial community, sIgA-coated and sIgA-uncoated B. longum subsp. infantis and B. pseudocatenulatum was dominant in infant feces and maternal feces, respectively. The relative abundance of sIgA-uncoated B. longum subsp. infantis was significantly higher in infant feces compared to that in maternal feces. For the Lactobacillus community, L. paragasseri and L. mucosae were dominant in infant and maternal feces, respectively. HBM and infant and maternal feces showed distinct diversity and composition of both sIgA-coated and sIgA-uncoated bacteria at genus level. Infant and maternal feces showed similar composition of Bifidobacterium at species level. The same Bifidobacterium species could be detected both in sIgA-coated and -uncoated form. This article provided deeper understanding on the microbiota profile in HBM and infant and maternal feces.
PDF
